There is an increased risk of 30-day mortality among hospitalized children with carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical cultures compared to those with carbapenem-susceptible Enterobacteriaceae (CSE), with significant variation in antibiotic treatment for those with CRE infections. This according to a multicenter matched cohort study that assessed the impact of isolation of CRE from a clinical culture on 30-day all-cause mortality relative to isolation of CSE. All patients aged <21 years hospitalized at 3 different hospitals between January 1, 2011, and July 1, 2016 were eligible for inclusion. Patients with index clinical cultures positive for CRE were matched in a 2:1 ratio to those with clinical cultures positive for CSE. Researchers found:
- During the 5.5-year study period, 72 patients with a clinical culture positive for CRE were identified and matched to 144 control patients with a clinical culture positive for CSE.
- Patients with CRE had a 6-fold greater risk of mortality relative to patients with CSE.
- There was significant variation in antibiotic treatment strategies among infected patients.
Chiotos K, Tamma PD, Flett KB, et al. Increased 30-day mortality associated with carbapenem-resistant Enterobacteriaceae in children. [Published online ahead of print September 10, 2018]. Open Forum Infect Dis. doi:10.1093/ofid/ofy222.
Must Reads in Antimicrobial-resistant infections
Antibiotic Use and Hospital Onset CDI Infection, Clin Infect Dis; ePub 2019 Mar 1; Kazakova, et al
Patient Follow-Up in OPAT & Readmissions, Clin Infect Dis; ePub 2019 Feb 27; Palms, et al
Decolonization Lowers Postdischarge Infection Risk, N Engl J Med; 2019 Feb 14; Huang, et al
Antibiotic Stewardship & Fluoroquinolone Prescribing, Clin Infect Dis; ePub 2019 Feb 13; Vaughn, et al
30-Day Readmission After S. aureus Bacteremia, Clin Infect Dis; ePub 2019 Feb 11; Inagaki, et al